GABBR2 and glioblastoma: Comparative analysis of switching chromatin states between GIC and iNSC identified novel pharmacologically targetable genes, including SMOX and GABBR2 in a subgroup of glioblastoma, which could be further explored as new therapeutic approaches to counteract glioblastoma invasiveness.